Objective: Exaggerated inflammatory response occurs in preeclampsia. Preeclampsia is also associated with elevated endogenous digoxin-like factors (EDLFs). Clinical data suggest that Digibind (a polyclonal sheep digoxin binding Fab fragment) binds to EDLF and may have the potential to attenuate vasoconstriction and other clinical symptoms of preeclampsia. This study was undertaken to determine if Digibind could attenuate increased endothelial inflammatory response induced by tumor necrosis factor-a (TNFa).
Introduction
It was reported that circulating levels of endogenous digoxin-like factor(s) such as ouabain, bufadienolide, marinobufagenin, and cardenolide were elevated in women with preeclampsia, 1-3 a hypertensive and multiple system disorder unique to human pregnancy. Studies have shown that digoxin-like factors extracted from plasma from women with preeclampsia could inhibit erythrocyte Na þ /K þ -ATPase activity 3 and Na þ /K þ -ATPase purified from human mesenteric arteries. 2 Inhibition of the sodium pump could result in an increase in intracellular calcium levels and lead to vasoconstriction in the systemic vasculature. Therefore, the vasoconstrictive property of digoxin-like factors is believed to contribute to maternal hypertension in preeclampsia.
Endothelial activation/dysfunction is a central pathophysiological feature in the maternal vascular system in preeclampsia. 4 Pregnancy is also an inflammatory state and preeclampsia is considered to be an exaggerated inflammatory response during pregnancy. 5 It is believed that altered endothelial function constitutes the exaggerated inflammatory response in this pregnancy disorder, 5 which includes activation of leukocytes and platelets, increased circulating cytokine levels of tumor necrosis factor-a (TNFa), interferon-g and interleukin-6 6,7 and increased endothelial adhesion molecule levels such as intercellular adhesion molecule (ICAM) and vascular cell adhesion molecule (VCAM). 8, 9 Digibind is a polyclonal-fragmented Digoxin-immune Fab antibody raised in sheep. Previous published work has shown that in vitro treatment of erythrocytes from preeclamptic patients with Digibind could restore the cell Na þ /K þ -ATPase activity. 3 Furthermore, administration of Digibind to both antepartum and postpartum women with preeclampsia could improve maternal symptoms and increase fetoplacental perfusion 10, 11 (Dr Adair's unpublished data), which suggest that Digibind could be a potential therapy for preeclampsia. To study if Digibind exerts beneficial effects on endothelial cells, we examined the role of Digibind in TNFa-induced inflammatory response in endothelial cells. Endothelial surface adhesion molecule expressions ICAM, VCAM and E-selectin were used as the endpoint readout. Effects of Digibind on endothelial extracellular signal-regulated kinases (ERKs) and Na þ /K þ -ATPase expressions affected by cytokine TNFa were also examined.
Methods

Endothelial isolation and culture
Human umbilical vein endothelial cells were isolated by collagenase digestion as previously described. 12 Umbilical cords were collected from normal pregnant women after delivery at Louisiana State University Health Sciences Center in Shreveport hospital. Normal pregnancy was defined as a pregnancy in which the mother had normal blood pressure (p140/90 mm Hg), absence of medical and obstetrical complications. This study was approved by the Institutional Review Board for Human Research at LSUHSC-Sh, LA.
Isolated cells were incubated with endothelial cell growth medium (BioWhittaker Inc., Walkersville, MD, USA). Only the firstpassage (P1) endothelial cells were used in this study. Cells used for adhesion molecule expression experiments were grown in 48 wells per plate and cells used for protein extraction were grown in 25 cm 2 Endothelial surface molecule expression assay Cellular surface molecule expressions for ICAM, VCAM and E-selectin were determined as we previously described. 12 Briefly, after endothelial cells were treated with TNFa or combined with Digibind in culture, cells were fixed with 1% paraformaldehyde and then incubated with a primary antibody (mouse anti-human) to ICAM-1 (CD54), VCAM-1 (CD106) or E-selectin (CD62E), respectively. Horseradish peroxidase-goat anti-mouse immunoglobulin G (Sigma) was used as the secondary antibody. Hydrogen peroxide (0.003%) and 3,3 0 ,5,5 0 -tetramethybenzidine (TMB) (0.1 mg ml À1 ) were used as substrate and color generation. The reaction was terminated by 8 N H 2 SO 4 . Cells that reacted with secondary antibody only were used as background. After reaction, plates were read at 450 nm by an autoplate reader (Molecular Devices, Sunnyvale, CA, USA). All samples were tested in triplicate.
Western blot analysis
At the end of each experiment, total cellular protein was extracted with an ice-cold lysis buffer that contained 50 mmol l
À1
Tris-HCl (pH7.6), 1% Triton X-100, 0.5% NP-40, 1 mmol l À1 phenylmethylsufonyl fluoride and 0.5%mmol l À1 dithiotheritol. The lysate was centrifuged at 14 000 r.p.m. at 4 1C for 15 min to remove insoluble materials. All samples were stored at À70 1C. The total endothelial cell protein extract (10 mg per sample) was subjected to electrophoresis on 12% polyacrylamide gels by using the Mini-protein 3 gel running system (Bio-Rad, Hercules, CA, USA) and then transferred to nitrocellulose membrane. The membranes were probed with a primary monoclonal antibody against ERK (Santa Cruz, San Diego, CA, USA), pERK (Santa Cruz), Na þ /K þ -ATPase b1 (Santa Cruz) or b-actin (Sigma). The secondary antibody was horseradish-linked anti-mouse antibody. The bound antibodies were visualized with an enhanced chemiluminescent deletion Kit (Amersham Corp., Arlington Heights, IL, USA). Nitrocellulose membranes were stripped and blocked before they were probed again with different primary antibodies.
Statistical analysis
Data are presented as mean ± s.e. Statistical analysis was performed with analysis of variance by a computer software program StatView (SAS Institute Inc., Cary, NC, USA). A probability level less than 0.05 was considered statistically significant.
Results
Digibind attenuates TNFa-induced endothelial surface adhesion molecule expressions
Endothelial inflammatory response was induced by cytokine TNFa. Confluent endothelial cells were treated with TNFa at concentrations of 1, 10 and 100 pg ml À1 for 2 h, then endothelial adhesion molecule ICAM, VCAM and E-selectin expressions were determined. TNFa at a concentration of 100 pg ml À1 was relative compatible with the TNFa levels in the maternal plasma in women with preeclampsia.
13 Figure 1 shows dose-dependent increase in endothelial ICAM, VCAM and E-selectin expressions induced by TNFa.
TNFa at lower dose (1 pg ml À1 ) had no effects on endothelial ICAM, VCAM and E-selectin expressions compared to the controls, ICAM: 0.645 ± 0.028 vs 0.564 ± 0.036; VCAM: 0.101 ± 0.005 vs 0.090 ± 0.002; and E-selectin: 0.073 ± 0.011 vs 0.070 ± 0.014, respectively. Endothelial ICAM, VCAM and E-selectin expressions were significantly increased when TNFa concentrations were used at 10 pg ml À1 (P<0.05) and 100 pg ml À1 (P<0.01)FICAM: 1.261 ± 0.067 and 1.789 ± 0.143; VCAM: 0.236 ± 0.032 and 0.663±0.072; and E-selectin: 0.128±0.020 and 0.345±0.007, respectively.
To determine if Digibind could attenuate TNFa-induced ICAM, VCAM and E-selectin expressions in endothelial cells, cells were pretreated with Digibind for 1 h and then TNFa at a concentration of 100 pg ml À1 for 2 h. Two concentrations of Digibind (50 and 100 mg ml À1 ) were used. Figure 2 shows that Digibind could dosedependently attenuate TNFa-induced upregulation of endothelial ICAM, VCAM and E-selectin expressions, Digibind at 50 pg ml À1 þ TNFa and at 100 pg ml Digibind reduces TNFa-induced endothelial surface adhesion molecule expressions To further determine if Digibind could reduce cytokine TNFa induced endothelial activation, ECs were first treated with TNFa for 1 h and then Digibind was added to the cell culture. The cells were continuously cultured for 1 h and ICAM and VCAM and E-selectin expressions were determined. In this experiment, two concentrations of TNFa (10 and 100 pg ml À1 ) were used. Interestingly, endothelial ICAM, VCAM and E-selectin expressions were downregulated in cells even when Digibind was added to the cell culture after TNFa treatment (Figure 3) , addition of Digibind 100 pg ml À1 vs TNFa at 100 pg ml À1 aloneFICAM: 0.896 ± 0.12 vs 1.435±0.192, P<0.05; VCAM: 0.413±0.062 vs 0.584±0.071, P<0.05; and E-selectin: 0.256 ± 0.034 vs 0.498 ± 0.086, P<0.01, respectively. These data suggest that Digibind exerts protective effects on endothelial cells against cytokine TNFa induced endothelial activation.
Digibind attenuates TNFa-induced downregulation of Na þ /K þ -ATPase b1 expression, but has no effect on TNFainduced ERK phosphorylation in endothelial cells It is known that cytokine induced inflammatory response is involved in extracellular signal-regulated kinases (ERKs) activation. Using ERK expression as a comparison, we examined if increased endothelial adhesion molecule expression induced by TNFa is associated with alteration of Na þ /K þ -ATPase expression in endothelial cells. Endothelial cells were treated with TNFa at different concentrations and then ERK, pERK and Na þ /K þ -ATPase expression were examined by western blot analysis. Figure 1 Tumor necrosis factor-a (TNFa) dose-dependently increased in endothelial ICAM, VCAM and E-selectin expressions. Data are means from six independent experiments, each in triplicate. *P<0.05, **P<0.01, respectively.
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As shown in Figure 4 , TNFa induced upregulation of ERK phosphorylation (pERK) was in a dose-dependent manner. In contrast, Na þ /K þ -ATPase b1 expression was downregulated in endothelial cells treated with TNFa. The TNFa induced inhibitory effect on Na þ /K þ -ATPase b1 expression was also in a dose-dependent manner. We further determined if Digibind-exerted protective effects against TNFa-induced downregulation of Na þ /K þ -ATPase b1 expression in endothelial cells. As shown in Figure 5a , pretreatment of Digibind did not affect pERK expression in endothelial cells stimulated with TNFa. In contrast, pretreatment of Digibind could attenuate TNFa-induced downregulation of Na þ /K þ -ATPase b1 expression (Figure 5b ).
Discussion
In this study, using TNFa as an inflammatory stimulator we examined potential beneficial effects of Digibind on vascular endothelial cells. We found that TNFa could not only induce an endothelial inflammatory response as evidenced by upregulation of endothelial surface adhesion molecule expression and induction of ERK phosphorylation, but also downregulate Na þ /K þ -ATPase expression in endothelial cells. Na þ /K þ -ATPase is important cell membrane ionic machinery, which keeps membrane potential in a proper order and maintains intracellular and extracellular ionic balance. TNFa induced upregulation of endothelial adhesion molecule ICAM, VCAM and E-selectin expressions, accompanied by downregulation of Na þ /K þ -ATPase expression, suggest that enhanced endothelial inflammatory response may associate with altered Na þ /K þ -ATPase activity or function in endothelial cells. One of the most important findings of our study is that Digibind may have protective effects to offset endothelial inflammatory response as demonstrated not only by attenuating but also by reducing TNFa-induced increased endothelial inflammatory responses determined by E-selectin, ICAM and VCAM expressions on the endothelial surface. Both in vivo and in vitro studies have shown that enhanced adhesion molecule expression in endothelial cells is directly related to activation of leukocytes, increased leukocyte-endothelial adhesion and leukocyte extravasation. 14, 15 In preeclampsia, maternal TNFa levels, as well as soluble levels of E-selectin, ICAM and VCAM are elevated compared to normal pregnant controls. 9, 16 As maternal circulating levels of endogenous digoxin-like factor(s) are also increased in women with preeclampsia, 1,2 Digibind may not only be able to neutralize endogenous digoxin-like factor(s) in the circulation but also exert protective effects on vasculature by reducing endothelial inflammatory response in preeclampsia.
In this study, we also found that TNFa down-regulated endothelial Na þ /K þ -ATPase b1 expression, suggesting that increased inflammatory response is accompanied by altered sodium pump activity or function on the cell membrane. Regarding the fact of reduced Na þ /K þ -ATPase activity in erythrocytes from women with preeclampsia, 1,2 our finding of downregulation of Na þ /K þ -ATPase b1 expression induced by TNFa indicated that increased endothelial inflammatory response may directly or indirectly influence endothelial Na þ /K þ -ATPase activity or function. This concept is supported by our data that TNFa-induced downregulation of endothelial Na þ /K þ -ATPase b1 expression could be blocked by pretreatment of endothelial cells with Digibind in culture.
At the present time, we do not know the direct relationship of upregulation of endothelial adhesion molecule expression to downregulation of Na þ /K þ -ATPase b1 expression stimulated by TNFa in endothelial cells. Our data showed that upregulation of E-selectin, ICAM and VCAM expression was related to upregulation of phosphorylated EKR expression in endothelial cells after TNFa stimulation, which indicates that TNFa-induced endothelial inflammatory response is an transcriptional factor regulated event, at least in part, through the ERK pathway regulation. However, Digibind could attenuate or reduce TNFa-induced endothelial adhesion molecule expression, but had no effects on TNFa-induced pERK upregulation. These observations suggest that attenuation of TNFa-induced endothelial adhesion molecule expression by Digibind is not mediated through the ERK pathway regulation.
This study further supports the potential function of Digibind for a possible clinical application for preeclampsia patients. The recently reported Digibind Efficacy Evaluation in Preeclampsia (DEEP) study, Gov trial no. NCT00158743, showed improved renal hemodynamic effects of Digibind on preterm severe preeclampsia, which correlated with improved erythrocyte sodium potassium ATPase pump function. 17, 18 As pump inhibition maintains several key cellular membrane functions, Digibind potentially may exert its observed clinical benefit by reversal of sodium pump inhibition followed by improving cell membrane function. 18 These observed effects would not have limitation to preeclampsia only but could hypothetically be extrapolated to other diseases related to the increased inflammatory response and would imply a potential platform technology for Digibind. Na þ /K þ -ATPase is a highly conserved ubiquitous membrane protein, which is composed of three subunits: a, b and g. We found that TNFa had no effect on Na þ /K þ -ATPase a-subunit expression (data not shown), but downregulation of b-subunit was observed. Interestingly, Digibind could block the downregulation of b-subunit expression induced by TNFa in endothelial cells. Although the exact mechanism of Digibind preservation of the b-subunit is not clear, studies have shown that b-subunit may be more intimately involved in the mechanism of active transport function of Na þ /K þ -ATPase, 19 as the cation affinity of the Na þ /K þ -ATPase can be affected by changes in the b-subunit, 19, 20 which indirectly supports our data that Digibind could preserve the b-subunit function in vascular endothelium.
In summary, in this study we found that Digibind could attenuate cytokine TNFa-induced increased endothelial surface adhesion molecule expression and decreased Na/K-ATPase b1 expression in cultured endothelial cells. As it is impossible to obtain maternal systemic vessels during pregnancy, it limits us to directly study the endothelial response to Digibind in an in vivo situation such as in preeclampsia. However, the DEEP study result that Digibind could reverse erythrocyte Na/K-ATPase pump function 18 supports the idea that Digibind may exert protective effects on vascular endothelial function by restoring Na/K-ATPase pump function and increase the pump activity. Although the Digibind action on endothelial function is largely unknown, our data do suggest that Digibind may exert antiinflammatory effects on vascular endothelial cells, the mechanism of which warrants further investigation.
